Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

France

 

PAI Partners seeks sovereign wealth fund boost for Sanofi consumer healthcare bid

PAI Partners, the French private equity firm, is in talks with two of the world's largest sovereign wealth funds to support its offer for Sanofi SA's consumer health division. According to anonymous Bloomberg sources, the Abu Dhabi Investment Authority (ADIA) and Singapore's GIC Pte are considering joining PAI's consortium. The deal could value the business […]

Surprise result in France’s national assembly elections as left wing alliance comes out on top

No clear path for the French parliament with no grouping capable of securing a majority, as the far-right National Rally unexpectedly falls to third. The second round of the French National Assembly elections produced a shock perhaps even greater than that delivered by the National Rally’s successful European elections, as the left wing alliance defied earlier polling and emerged as the biggest grouping in the legislature.

PMI’s changing business model

Access to primary care is now the number one reason people in the UK want private medical insurance (PMI), according to data collected by UK health insurer Vitality. Other NHS countries have been seeing similar trends since Covid. Katie Tryon, Vitality’s Director of Health Strategy, spoke about how this has completely changed the PMI business model — for the better — at HBI’s conference last month.

Eurofins’ share price falls after allegations it is “optimised for malfeasance”

Multinational French labs group Eurofins saw its share price lose almost a quarter of its value on Monday after US investigative research and investment firm Muddy Waters released a report highlighting numerous “oddities and contradictions” which it believes suggest the group is “optimised for malfeasance”. The share price regained most of its lost value after Eurofins published a rebuttal which addressed some of the issues raised in the report. However questions still remain, most pertinently over allegations that the firm’s CEO and founder, Gilles Martin, has been using real estate to “siphon” off money from the company.

Find Us